Temasek leads new round of funding for French veterinary pharma firm
Add BT as a preferred source
Vivienne Tay
DeeperDive is a beta AI feature. Refer to full articles for the facts.
SINGAPORE'S Temasek Holdings has led a new round of funding for French veterinary health company Ceva Santé Animale.
New investors joining the funding round include France's Téthys Invest, Canada's PSP Investments, Japan's Mitsui & Co and Germany's Klocke Gruppe. Reinvesting in this round are French shareholders Sofiproteol and Merieux Equity Partners.
According to Ceva, all historic minority investors have also agreed to roll over a significant portion of their investments to further participate in and contribute to the company's future growth.
Other minority investors include EMZ and Sagard from France, Chinese private equity fund Hopu Investments, and food and agribusiness group Continental Grain Company.
Temasek had in June 2014 made an equity investment in Ceva, which specialises in the research, development, production and marketing of products and vaccines for companion animals, ruminants, swine and poultry.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Vietnam formalises new state leadership, redefining ‘four pillars’ power balance
‘Largest Singapore commercial S-Reit proxy’: analysts say buy CICT shares after Paragon acquisition
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
Why where you park your joint venture matters: Lessons from a US$689 million shareholder dispute
